During the coronavirus pandemic, some pharmacies in Texas are experiencing certain drug shortages. Bobcat Update's Krista Andrews has the story.
President Trump has advocated use of hydroxychloroquine, a drug traditionally used to treat malaria and lupus, as a treatment option for COVID-19 patients. However, according to the Food and Drug Administration, the drug is now in short supply and unproven as an effective treatment for COVID-19. Pharmacist Dustin Andrews says the Texas Board of Pharmacy has issued procedures to help prevent hydroxychloroquine shortages in the state.
SB (Dustin Andrews, Texas Pharmacist)
Despite the new guidelines, some worry that the president's comments could still affect the drug's availability. Texas State Professor Cassandra LeClair is diagnosed with lupus and has been prescribed hydroxychloroquine since 2011.
SB (Cassandra LeClair, Senior Lecturer)
To help meet the increased demand for the drug, the F-D-A has issued an emergency use authorization allowing states to distribute (m) millions of hydroxychloroquine stockpiled from pharmaceutical companies. For Bobcat Update, I'm Krista Andrews.
Bobcat Update, a student-produced newscast recapping events at Texas State University, and is available for viewing on YouTube.
No comments:
Post a Comment